Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil with remimazolam for painless gastroscopy and colonoscopy
ChiCTR2100043890Phase 4Recruiting
- Sponsor
- Xiang'an Hospital of Xiamen University
- Start
- May 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Alfentanil combined with propofol group, Alfentanil combined with remimazolam besylate group and Sufentanil combined with remimazolam besylate group (3 arms). Primary endpoint: Respiratory depression. Started May 2021; status: recruiting.
02
Drugs
alfentanilremimazolampropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2100043890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043890.